• Invest
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Product Suite
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    All Calculators
    Product Suite
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Market Movers
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Commodities
    Currency
    Futures & Options
    Derivatives
    Margin Trading
    Events
    Budget 2024
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2024
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Fund Expert
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement

Top Pharma Stocks to Invest

  •  4 min read
  • 0
  • 04 Sep 2024
Top Pharma Stocks to Invest

Indian pharma stocks have performed exceptionally well over the last year. Data shows that the Nifty Pharma Index has surged 58% in the 12 months, outperforming the Nifty 50. The Indian pharma market, valued at USD 49 billion in 2022, is expected to reach USD 450 billion by 2047 and clock a CAGR of 9% in the coming years.

With the pharma industry poised for significant growth in the coming year, adding pharma stocks to your portfolio can help create wealth for you in the long run.

Pharma stocks refer to stocks of companies within the pharmaceutical industry that are engaged in the research, development, manufacturing, and marketing of medicines for treating various medical conditions. These stocks can include stocks of large and established pharmaceutical firms, biotech companies, and generic drug manufacturers.

Stock’s Name 3-year Trailing Returns (As of 8th July 2024) Overview
Aster DM Healthcare Ltd
17.10%
Aster DM Healthcare Ltd is a prominent healthcare services provider. Over the years, it has grown into a network of hospitals and clinics delivering comprehensive medical services across its markets.
Cipla Ltd
17.86%
An Indian multinational pharma company, Cipla Ltd has carved out a niche with its innovative products and commitment to affordable healthcare. Its dedication to quality has made it a trusted name in the pharma industry.
Sun Pharmaceuticals Industries Ltd
18.67%
Founded in 1983 by Dilip Shanghvi, Sun Pharma has grown into a global leader in the pharmaceutical sector, with a significant presence in over 100 countries. It is recognised for its robust R&D capabilities and strategic acquisitions.
Torrent Pharmaceuticals Ltd
46.36%
Founded in 1959, Torrent has established a significant presence in India and internationally, particularly in regulated markets like the US and Europe.

Source: Kotak Securities

Keep in mind the following things for identifying the best-performing pharma stocks:

  • Fundamental analysis

Carry out the company's fundamental analysis. Look at the company's earnings growth, profit margins, and debt levels, among other factors, to identify profitable firms.

  • Analyse the stock's historical performance

Check the stock's historical performance. Look at past trends and check how the stock has responded to market volatility. It is prudent to opt for stocks with consistent growth.

  • Keep an eye on industry trends

Industry trends, including global healthcare dynamics, can significantly impact pharma stocks. To make intelligent decisions, keep an eye on these trends and check how your chosen stock responds to them.

Apart from the above factors, you should look at these things before investing in pharma stocks:

  • Global and domestic demand

Analyse domestic and global demand to determine whether the stock is poised for growth in the coming days. Various domestic and global factors and trends, such as the prevalence of diseases and healthcare spending, influence pharma stocks.

  • Government policies

The pharma industry is tightly regulated, and government policies can impact a company's ability to launch new products. Stay updated on regulatory changes and policies to learn potential challenges that a company may face.

  • Competitive landscape

The pharma industry is competitive. Evaluating a company's competitive landscape can provide insights into its long-term growth potential.

The Indian pharmaceutical industry currently occupies the third rank in pharmaceutical production by volume, and India has the highest number of pharmaceutical manufacturing facilities complying with the US Food and Drug Administration (USFDA). The industry supplies over of the global demand for various vaccines and enjoys an important position in the global pharmaceutical sector. It contributes around 1.72% of the country's GDP.

Several government initiatives such as increasing the number of Pradhan Mantri Bhartiya Jan Aushadi Kendras and approving of the National Medical Devices Policy, 2023, among others is expected to bolster the industry in the coming days.

Investing in top-rated pharma stocks has become easier with Health is Wealth Basket. Stocks curated by Kotak Securities research analysts, this basket allows you to invest in pharma stocks hassle-free. Click here to know more.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI’s prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262. For compliance T&C and disclaimers, Visit bit.ly/ksecdisc

Did you enjoy this article?

0 people liked this article.

What could we have done to make this article better?

Enjoy Free Demat Account Opening
+91 -

personImage
Enjoy Free Demat Account Opening
+91 -